Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
33 Results for "
p17
" in MedChemExpress (MCE) Product Catalog:
Products (33)
33 Results for "p17" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-P71432
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: WFDC2; WAP Four‑Disulfide Core Domain 2; WAP5; HE4; WAP Four‑Disulfide Core Domain Protein 2; DJ461p17.6; EDDM4; Major Epididymis‑Specific Protein E4; Putative Protease Inhibitor WAP5; Epididymal Secretory Protein E4; Human Epididymis Protein 4; Epididyma
Cat. No.: HY-P1485A
CAS No.: 2828433-22-1
Target:
Research Areas:
Cat. No.: HY-P10634
CAS No.: 846546-36-9
Target:
Research Areas:
Cat. No.: HY-W587733
CAS No.: 1662-06-2
Synonyms: 17,20β-P; 17,20β-DHP
Research Areas:
17α,20β-Dihydroxy-4-pregnen-3-one (17,20β-P; 17,20β-DHP) acts as the maturation-inducing hormone (MIH) in salmonid fish and rainbow trout. 17α,20β-Dihydroxy-4-pregnen-3-one binds to oocyte-specific plasma membrane receptors and pertussis toxin-sensitive inhibitory G proteins in fish, inhibits Adenylate Cyclase and reduces intracellular cAMP via the membrane receptor-G protein coupling pathway, thereby initiating downstream signal transduction. 17α,20β-Dihydroxy-4-pregnen-3-one induces de novo synthesis of cyclin B, mediates the translation of cyclin B mRNA and the phosphorylation of cdc2, and promotes the production of maturation-promoting factor (MPF). 17α,20β-Dihydroxy-4-pregnen-3-one drives meiotic maturation of fish oocytes. 17α,20β-Dihydroxy-4-pregnen-3-one is applicable for development-related research .
Cat. No.: HY-P1757
CAS No.: 147468-65-3
Cat. No.: HY-P1485
CAS No.: 68060-49-1
Target:
Research Areas:
Cat. No.: HY-N1059
CAS No.: 119642-82-9
Target:
Cat. No.: HY-170793
CAS No.: 2978623-09-3
Target:
Research Areas:
PD-L1/VISTA-IN-1 (Compound P17) is an orally active dual-target inhibitor of PD-L1 and VISTA. PD-L1/VISTA-IN-1 can block the PD-1/PD-L1 interaction (IC50: 0.1492 μM) and the VISTA pathway (KD: 0.2723 μM), thereby reactivating T cells. PD-L1/VISTA-IN-1 has anti-tumor activity .
Cat. No.: HY-RS04718
Target:
Research Areas:
FAM72A Human Pre-designed siRNA Set A contains three designed siRNAs for FAM72A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-183376
CAS No.: 126103-94-4
Target:
Research Areas:
U 81749 is a competitive, reversible HIV-1 protease inhibitor with a Ki value of 70 nM. U 81749 inhibits HIV-1 protease within HIV-like particles, blocks the processing of the HIV-1 gag polyprotein p55 into the mature structural proteins p24 and p17, and thereby prevents viral maturation. U 81749 reduces HIV p24 and HIV RNA levels in acutely infected human lymphocytes, and shows no toxicity to lymphocyte proliferation at effective concentrations. U 81749 can be used in studies related to HIV-1 infection .
Cat. No.: HY-RS10827
Target:
Research Areas:
POLE3 Human Pre-designed siRNA Set A contains three designed siRNAs for POLE3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P704058
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: vif; Virion infectivity factor; Vif; SOR protein; p17; p7
Species:
Source:
Cat. No.: HY-129931
CAS No.: 15893-46-6
Synonyms: H-Phe-Phe-NH2
Target:
Research Areas:
Phenylalanylphenylalanylamide (H-Phe-Phe-NH₂) is a ligand for the substance P 1–7 (SP1-7) binding site with a Ki value of 1.5 nM. Phenylalanylphenylalanylamide exerts significant anti-allodynic and anti-hyperalgesic effects in animal models of neuropathic pain following central administratio. Phenylalanylphenylalanylamide shows no distinct effect after peripheral (intraperitoneal) administration. Phenylalanylphenylalanylamide can be used for research on pain-related diseases .
Cat. No.: HY-168729
CAS No.: 3052804-28-8
Antibacterial agent 256 (Compound C09) is an inhibitor for type I signal peptidase (SPase I). Antibacterial agent 256 inhibits gram-positive bacteria, that inhibits S. aureus ATCC 29213, E. faecium QF31, E. faecalis SF23-1 and S. suis P1/7, with MIC of 1-16 μg/mL. Antibacterial agent 256 exhibits cytotoxicity in cancer cell HEp-2 and Caco-2 with CC50 of 14.65 μg/mL and 21.93 μg/mL. Antibacterial agent 256 exhibits a hemolytic activity on mouse RBCs, with an HC50 of 13.29 μg/mL. Antibacterial agent 256 ameliorates the MRSA skin infection in mouse model .
Cat. No.: HY-P704203
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Allergen Ara h 1; Ara h 1; clone p17; Allergen Ara h I; allergen Ara h 1
Cat. No.: HY-P704051
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Gag polyprotein; Pr55Gag; Matrix protein p17; MA; Capsid protein p24; CA; Spacer peptide 1; SP1; p2; Nucleocapsid protein p7; NC; Spacer peptide 2; SP2
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
